Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
about
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.Cerebral melanoma metastases: a critical review on diagnostic methods and therapeutic options.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Temozolomide for the treatment of metastatic melanomaSystemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine.Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.Gamma knife radiosurgery in the management of malignant melanoma brain metastases.Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.
P2860
Q33557548-18B6D46B-80B8-4731-98B1-0848A1A835A9Q34074745-7B312D2B-5248-48CD-93FB-9D684B0CEF8DQ35838744-D9EA7742-C659-452C-9ECC-EFB201BCA145Q36852256-25435AA7-5635-4AF4-87FB-08E2A9E7C308Q36980823-EF63DCE6-50F4-46FC-BD94-8768AC67B247Q44990894-308DE37D-71BF-433B-B811-97EA9313DAC6Q48258912-0E9E8050-02EC-4BB2-8D45-2638EFBAFC3AQ48567066-128DCA44-BC60-4CF7-9D34-16B50764E3FD
P2860
Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Temozolomide in combination wi ...... phase I dose-escalation study.
@ast
Temozolomide in combination wi ...... phase I dose-escalation study.
@en
type
label
Temozolomide in combination wi ...... phase I dose-escalation study.
@ast
Temozolomide in combination wi ...... phase I dose-escalation study.
@en
prefLabel
Temozolomide in combination wi ...... phase I dose-escalation study.
@ast
Temozolomide in combination wi ...... phase I dose-escalation study.
@en
P356
P1433
P1476
Temozolomide in combination wi ...... phase I dose-escalation study.
@en
P2093
John M Kirkwood
Sanjiv S Agarwala
P304
P356
10.1002/CNCR.11041
P407
P577
2003-01-01T00:00:00Z